Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SRNE crawled time : 18:00 save search
Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records from certain Brokers, Dealers, Banks and other Nominees Pursuant to Rule 2004 of the Federal Rules of Bankruptcy Procedure
Published: 2023-10-27 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
| Email alert
Add to watchlist
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
| Email alert
Add to watchlist
company order
Antibody Drug Conjugate - Competitive Landscape 2023 Study: Featuring Coverage on 180+ Companies and 300+ Drugs
Published: 2023-06-30 (Crawled : 18:00) - prnewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
IMGN | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
drug companies antibody
Sorrento Therapeutics, Inc.'s Bankruptcy Court Requires Brokerages to Provide Information Related to Scilex Common Stock
Published: 2023-04-04 (Crawled : 18:00) - prnewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: 0.86%
H: 0.0%
C: -3.65%
BR | $193.38 0.21% 0.0% 390K
|
Commercial Services
|
| O: 0.3%
H: 0.51%
C: -1.45%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 2.77%
H: 0.0%
C: -7.47%
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
Published: 2023-03-29 (Crawled : 18:00) - prnewswire.com
MC | $51.65 1.33% 0.0% 590K
|
Finance
|
| O: 1.57%
H: 0.05%
C: -1.6%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -1.47%
H: 7.1%
C: 4.48%
approval
Sorrento Therapeutics has Received FDA Clearance to Initiate Clinical Trials with a Next Generation mRNA (STI-1557) Vaccine Against Omicron SARS-CoV-2 Virus
Published: 2022-12-06 (Crawled : 18:00) - biospace.com/
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -7.02%
sti-1557 fda clearance trials vaccine mrna virus therapeutics sars-cov-2
Sorrento Announces FDA Authorization to Proceed With Phase 1 Study Of Intranasal STI-9199 (COVISHIELD), a Potent Neutralization Antibody Against Covid-19 Viruses
Published: 2022-03-02 (Crawled : 18:00) - biospace.com/
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
sti-9199 covid-19 fda covid phase 1 authorization antibody
Sorrento Announces COVISHIELD (STI-9167) Antibody Strongly Neutralizes BA.2 Omicron Sublineage Virus as Well as BA.1 and BA.1+R346k Omicron Viruses
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -1.75%
H: 3.39%
C: -0.71%
sti-9167 antibody
Dr. Henry Ji, Sorrento Chairman and CEO, to Participate in the Virtual Cantor Global Healthcare Conference on September 29th, 2021
Published: 2021-09-27 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.02%
H: 3.66%
C: 2.91%
ceo conference
Sorrento Receives EUA Approval and Import License From Mexico Authority COFEPRIS For COVI-STIX™ (COVID-19 Virus Rapid Antigen Detection Test) and Plans Product Launch With Initial Shipments in July
Published: 2021-06-24 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 0.44%
H: 11.34%
C: 10.13%
covid test license approval authorized
Sorrento Enters Into Multi-Year Cooperative Research and Development Agreement With the U.S. Naval Medical Research Unit – No. 3 (NAMRU-3) For Pandemic Preparedness Combating COVID-19
Published: 2021-06-22 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -0.92%
H: 4.99%
C: 3.72%
covid research multi-year
Sorrento and Researchers at Karolinska Institutet Have Signed a Research Collaboration Agreement on iPSC-Derived Dimeric Antigen Receptor-Modified Natural Killer (DAR-NK) Cells With The Vision to Bring “Off-The-Shelf" NK Cell-Based Cancer Treatments Rapidly to Patients
Published: 2021-06-04 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.73%
H: 2.43%
C: -1.58%
treatment collaboration cancer research
Sorrento Therapeutics and Scilex Holding, a Majority Owned Subsidiary, Have Entered Into an Exclusive Licensing Term Sheet With Aardvark Therapeutics to Acquire Its ARD-301 For the Treatment of Chronic Pain, Fibromyalgia, and Chronic Long Haul Covid Syndrome
Published: 2021-03-01 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 4.1%
H: 6.2%
C: 1.83%
covid treatment fibromyalgia license chronic pain syndros
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen
Published: 2020-12-30 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 0.73%
H: 5.49%
C: 4.55%
test submission authorized sars-cov-2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.